Why good specialty pharmacy programs are falling behind
Visibility does not stop at the pharmacy. The same discipline that makes clinical and operational performance measurable is what links a program to stronger patient access and adherence outcomes, the results health systems feel most directly.
The shift from strong performance to proven outcomes
There was a time when a specialty pharmacy program could stand out by simply running well. If adherence was strong, workflows were stable, and patients were being served effectively, that was enough to be seen as high performing.
That definition no longer holds.
Today, the bar has moved. Payers, accreditors, and health system leadership are asking a different question. Not whether care is being delivered, but whether results can be consistently demonstrated, explained, and sustained.
Clinical performance still matters. But it is no longer the differentiator on its own.
The real gap is visibility, not capability
Many programs assume that performance gaps come down to clinical variation or staffing. In practice, that is rarely the issue.
The difference between programs that are operating well and those that are leading comes down to visibility. The ability to measure performance clearly, understand what is driving it, and act on it with consistency.
When teams can see their performance, they can improve it. When they cannot, decisions rely on experience and instinct. That works in day-to-day operations. It does not hold up when performance needs to be explained, compared, or improved under pressure.
Why “good” is no longer enough
What qualified as strong performance a few years ago has become the baseline expectation.
Programs are now being evaluated across multiple dimensions at once:
- Clinical outcomes
- Operational efficiency
- Financial performance
- Patient experience
Strong performance in one area is no longer sufficient. Leadership expects a complete picture. That is why many programs feel stuck. They are doing the work and delivering value. But they are not structured in a way that makes that value visible or repeatable.
Where performance breaks down
The challenge shows up in familiar ways. Adherence is tracked, but the impact of interventions is not clear. Time to therapy varies, but delays are difficult to trace. Quality efforts fluctuate around audit cycles. Patient feedback is collected, but not consistently used.
These are not isolated issues. They point to a broader pattern. Most programs are not failing. They are uneven across four critical domains:
- Adherence and clinical outcomes
- Time to therapy and operations
- Quality and accreditation
- Patient experience
Without a clear way to assess these areas together, improvement efforts lose focus.
A more useful way forward
Instead of asking whether a program is performing well, a better question is: Where are we today, and what would it take to move forward?
The Good, Better, Best framework provides a practical way to answer that. It replaces assumptions with clarity and helps teams align around what performance actually looks like in practice.
We will break that down in the next article.
What to do Monday morning
Start with a simple test. Ask your team to explain your program’s performance across all four domains without pulling reports. If the story is inconsistent, the issue is not effort. It is visibility.
.jpg)